Low-Dose Tirzepatide Improves Metabolic Health in Psoriasis and Obesity, suggests study Jacinthlyn Sylvia18 Jun 2026 10:15 PM ISTA new study published in the journal of Dermatology and Therapy showed that treatment with low-dose tirzepatide was linked to clinically significant...
Combined Tirzepatide and Ixekizumab Therapy Shows Dual Benefits in Psoriasis: JAMA Medha Baranwal17 May 2026 9:15 PM ISTUSA: A clinical trial has found that combining tirzepatide with ixekizumab led to significant improvements in skin clearance and weight reduction in...
GLP-1 Receptor Agonists Useful Adjunct in Psoriasis Management, Suggests Study Medha Baranwal5 May 2026 9:30 AM ISTUSA: Emerging evidence indicates that GLP-1 receptor agonists may play a supportive role alongside standard psoriasis therapies. Several studies have...
Biologics in Psoriasis Linked to Lower Risk of Ocular Surface Diseases: Study Jacinthlyn Sylvia23 April 2026 7:30 AM ISTA new study published in the recent issue of Eye journal revealed that among patients with psoriasis, use of biologic drugs (advanced...
SGLT2 Inhibitors Do Not Reduce Psoriasis Risk in T2DM: Study Dr Riya Dave17 April 2026 8:00 PM ISTSodium-glucose co-transporter 2 inhibitor (SGLT2i) therapy fails to lower the risk of new-onset psoriasis among patients with type 2 diabetes mellitus...
Sun Pharma to Present ILUMYA, LEQSELVI, WINLEVI Data at AAD 2026, Showcases Dermatology Advances Parthika Patel29 March 2026 11:30 AM ISTNew Delhi: Sun Pharmaceutical Industries Limited has announced that it will present 14 scientific abstracts highlighting advances in alopecia areata,...
From Psoriasis to Psoriatic Arthritis: Strategies for Early Risk Modification Dr. Bhumika Maikhuri9 March 2026 11:15 AM ISTKey Summary The transition from psoriasis to psoriatic arthritis (PsA) is driven by several modifiable risk factors, including obesity, severe...
Biologic Therapy safe in Psoriasis Patients With Active or Recent Malignancy, suggests research Jacinthlyn Sylvia1 March 2026 8:45 PM ISTA new study published in the Journal of American Academy of Dermatology showed that biologic therapies were linked to cancer progression, recurrence,...
Ixekizumab and tirzepatide combo Improves Skin Clearance and Weight Loss in Psoriasis Patients with Obesity: Study Dr. Kamal Kant Kohli19 Feb 2026 8:45 AM ISTNew findings indicate that in adults with moderate-to-severe plaque psoriasis who are overweight or obese, combined treatment with ixekizumab (Taltz)...
Psoriasis Linked to Erectile Dysfunction and Cardiovascular Risk: Study Jacinthlyn Sylvia13 Feb 2026 8:30 PM ISTA new study published in the journal of Dermatology Reports recognized psoriasis to be a risk factor for erectile dysfunction (ED), and the...
New gene discovery paves way for tailored psoriasis treatments, reveals research Dr. Kamal Kant Kohli8 Feb 2026 9:15 PM ISTA major new study has uncovered gene clues that could pave the way to personalised psoriasis treatments. Psoriasis is a common inflammatory skin...
Risankizumab Demonstrates Sustained Clinical and OCT Improvements in Psoriasis: Study Dr. Shravani Dali31 Jan 2026 8:30 AM ISTOver 52 weeks of treatment, risankizumab led to significant improvements in both clinical outcomes and optical coherence tomography (OCT) parameters,...
